Related Experiment Video
Updated: May 29, 2026

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Preoperative cardiac risk management
Radosav Vidaković1, Don Poldermans, Aleksandar N Nesković
1Department of Cardiology, Clinical Hospital Zemun, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Insights
Millions undergo noncardiac surgery yearly. This review details assessing and managing major adverse cardiac events (MACE) risk in these patients, crucial for improving perioperative outcomes.
Area of Science:
- Cardiology
- Anesthesiology
- Perioperative Medicine
Background:
- Noncardiac surgery is common globally, with approximately 3% of patients experiencing major adverse cardiac events (MACE).
- Perioperative cardiac complications contribute significantly to morbidity and mortality, yet their precise incidence is challenging to determine.
- Cardiac risk assessment is vital for optimizing patient management during noncardiac procedures.
Purpose of the Study:
- To review clinical risk factors, laboratory measurements, and non-invasive cardiac testing for assessing perioperative cardiac risk.
- To discuss strategies for managing patients undergoing noncardiac surgery based on their cardiac risk profile.
- To highlight the importance of preoperative cardiac evaluation for high-risk individuals.
Main Methods:
- Review of existing literature on perioperative cardiac risk assessment and management.
- Discussion of established scoring systems for predicting cardiac complications.
- Emphasis on non-invasive cardiac imaging modalities for preoperative evaluation.
Main Results:
- Perioperative cardiac risk is influenced by patient-specific risk factors and surgical procedure type.
- Scoring systems aid in accurately assessing and stratifying patient risk.
- Preoperative non-invasive testing guides management decisions, including medication or revascularization.
Conclusions:
- Accurate assessment of perioperative cardiac risk is essential for noncardiac surgery patients.
- Risk stratification enables tailored management strategies, including cardioprotective medications or myocardial revascularization.
- Integrating clinical evaluation, laboratory data, and non-invasive testing improves patient outcomes.
Abstract:
Approximately 100 million people undergo noncardiac surgery annually worldwide. It is estimated that around 3% of patients undergoing noncardiac surgery experience a major adverse cardiac event. Although cardiac events, like myocardial infarction, are major cause of perioperative morbidity or mortality, its true incidence is difficult to assess. The risk of perioperative cardiac complications depends mainly on two conditions: (1) identified risk factors, and (2) the type of the surgical procedure. On that basis, different scoring systems have been developed in order to accurately assess the perioperative cardiac risk and to improve the patient management. Importantly, patients with estimated high risk should be tested preoperatively by non-invasive cardiac imaging modalities. According to test results, they can proceed directly to planed surgery with the use of cardioprotective drugs (beta-blockers, statins, aspirin), or to myocardial revascularization prior to non-cardiac surgery. In this review, we discuss the role of clinical cardiac risk factors, laboratory measurements, additional non-invasive cardiac testing, and consequent strategies in perioperative management of patients undergoing noncardiac surgery.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization IV: Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Acute Coronary Syndrome IV: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
